Vikash Oza, Associate Professor of Dermatology and Pediatrics
Dr. Vikash (“Kashie”) Oza is an Associate Professor in Dermatology and Pediatrics at the NYU Grossman School of Medicine. He holds numerous leadership positions at the Ronald O. Perelman Department of Dermatology including serving as the Director of the Pediatric Dermatology Division, Associate Program Director for the Dermatology Residency Program and Director for the Pediatric Dermatology Fellowship. He received his Bachelor's degree in Sociology and Biology at the University of Chicago. Dr. Oza holds board certifications in Pediatrics, Dermatology and Pediatric Dermatology. He completed his pediatric residency at the Children's Hospital of Philadelphia and his dermatology residency and pediatric dermatology fellowship at the University of California at San Francisco School of Medicine. He is an active member of the Society for Pediatric Dermatology (SPD) and the Pediatric Dermatology Research Alliance (PEDRA). He serves as the chair of the PEDRA Best Practices Taskforce, PEDRA Studies Committee and is the co-director of the SPD Pediatric Dermatology Inpatient Special Interest Group. He has won multiple teaching awards in the both the departments of Dermatology and Pediatrics while on faculty at NYU. He is a frequently invited speaker regionally and nationally on a wide range of subject matter concerning pediatric dermatology. He has clinical and research interests in health literacy, atopic dermatitis, genetic dermatology, pediatric connective tissue disease, and medical education.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:Atopic Dermatitis low health literacy materialsDate added:06/21/2024Date updated:06/21/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:DermavantTopic:Consultant: Atopic dermatitisDate added:06/21/2024Date updated:06/21/2024Relationship end date:02/23/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:La Roche PosayTopic:Advisory board acneDate added:06/21/2024Date updated:06/21/2024Relationship end date:03/19/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:CeraveTopic:Advisory board Adolescent mental health skinDate added:06/21/2024Date updated:06/21/2024Relationship end date:05/23/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:IncyteTopic:Advisory board: Atopic dermatitisDate added:06/21/2024Date updated:06/21/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:National Eczema AssociationTopic:Atopic dermatitisDate added:06/21/2024Date updated:06/21/2024
-
Type of financial relationship:OtherIneligible company:PelthosTopic:Advisory board molluscumDate added:06/21/2024Date updated:06/21/2024Relationship end date:07/11/2024